PFKFB4

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 · Q16877 · PFKFB4 on Sugi Atlas →

2,374 patent compounds predicted against PFKFB4, 1,443 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL787754 SCHEMBL787754 1.00 14/20
SCHEMBL788108 SCHEMBL788108 1.00 14/20
SCHEMBL793576 SCHEMBL793576 0.60 13/20
SCHEMBL787865 SCHEMBL787865 1.00 12/20
SCHEMBL787888 SCHEMBL787888 1.00 12/20
SCHEMBL787986 SCHEMBL787986 1.00 12/20
SCHEMBL788033 SCHEMBL788033 1.00 12/20
SCHEMBL788169 SCHEMBL788169 1.00 12/20
SCHEMBL788343 SCHEMBL788343 1.00 12/20
SCHEMBL788157 SCHEMBL788157 0.80 12/20
SCHEMBL788203 SCHEMBL788203 0.77 12/20
SCHEMBL788469 SCHEMBL788469 0.77 12/20
SCHEMBL787664 SCHEMBL787664 0.76 12/20
SCHEMBL787908 SCHEMBL787908 0.74 12/20
SCHEMBL788594 SCHEMBL788594 0.74 12/20
SCHEMBL787889 SCHEMBL787889 0.72 12/20
SCHEMBL788755 SCHEMBL788755 0.68 12/20
SCHEMBL787869 SCHEMBL787869 1.00 11/20
SCHEMBL788058 SCHEMBL788058 1.00 11/20
SCHEMBL788791 SCHEMBL788791 0.90 11/20

Clinical trials — most relevant to PFKFB4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes PHASE4COMPLETED
Ketohexokinase Inhibition in NAFLD PHASE2COMPLETED
Acetylcarnitine and Insulin Sensitivity PHASE2COMPLETED
Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome PHASE2COMPLETED
Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC PHASE2UNKNOWN
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI PHASE1/PHASE2UNKNOWN
Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency PHASE2UNKNOWN
Bempedoic Acid Therapy for Polycystic Kidney Disease PHASE2NOT_YET_RECRUITING
Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers PHASE1COMPLETED
Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer PHASE1COMPLETED
Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults PHASE1RECRUITING
A Dose-Finding Study of AG-348 in Sickle Cell Disease EARLY_PHASE1COMPLETED
The Role of Sugars in Fat Accumulation in the Liver nanRECRUITING
Effect of Acute Fructose Load in Human nanCOMPLETED
Dried Fruit and Postprandial Glycemia Trial nanUNKNOWN
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours nanRECRUITING
Fructose and Glucose and TAS1R2 in Type 1 Diabetes nanCOMPLETED
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology nanCOMPLETED
Early Versus Late FDG-PET/CT in Bladder Cancer nanCOMPLETED
Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy nanCOMPLETED
Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome nanUNKNOWN
Thyroid Cancer and (FDG)PET/CT Scan nanUNKNOWN
Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer nanUNKNOWN
Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock Patients nanUNKNOWN
METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors nanRECRUITING
McArdle Disease Treatment by Ketogenic Diet nanCOMPLETED
13C Pyruvate DNP MR Spectroscopy for Lymphoma Treatment Response Assessment nanUNKNOWN
Nicotinamide Levels in Serum, Aqueous Humor, and Tear Film in Glaucoma and Correlations With Mitochondrial Damage-Associated Molecular Patterns (mtDAMPs) and Senescence-Associated Secretory Phenotype (SASP) nanNOT_YET_RECRUITING
Role and Expression of MXRA5 in Placental Connective Tissue Remodelling in Preeclampsia nanUNKNOWN
Circadian Brown Adipose Tissue Metabolism nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PFKFB4 binder may also engage these)

ProteinNameSimilarity
Q4R8B6 1.000 Q4R8B6 →
P25114 1.000 P25114 →
Q6DTY7 1.000 Q6DTY7 →
P70266 1.000 P70266 →
P49872 1.000 P49872 →
PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 1.000 landscape →
P07953 1.000 P07953 →
Q28901 1.000 Q28901 →
P70265 1.000 P70265 →
PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 1.000 landscape →
PFKFB1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 1.000 landscape →
Q91348 1.000 Q91348 →
Q91309 1.000 Q91309 →
Q9JJH5 0.999 Q9JJH5 →
Q5R9C1 0.998 Q5R9C1 →
Q21122 0.998 Q21122 →
P26285 0.997 P26285 →
O35552 0.996 O35552 →
P32604 0.996 P32604 →
Q5NVT1 0.996 Q5NVT1 →
Q8VYB2 0.989 Q8VYB2 →
Q9URZ7 0.988 Q9URZ7 →
O65583 0.988 O65583 →
Q9NWZ5 0.988 Q9NWZ5 →
Q9LK34 0.986 Q9LK34 →
Q55EL3 0.985 Q55EL3 →
Q91YL3 0.985 Q91YL3 →
Q9LTY6 0.985 Q9LTY6 →
Q5RAZ4 0.985 Q5RAZ4 →
Q9UTC5 0.985 Q9UTC5 →